Bayer Science And Innovation Private Limited, a active private limited company, was established on 16 January 1996 in Thane, Maharashtra, India. Engaging in seed production & distribution within the agriculture, forestry, fishing sector, it holds CIN: U24110MH1996PTC096340. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹350.00 Cr and a paid-up capital of ₹346.11 Cr.
Formerly known as Monsanto (India) Private Limited, Monsanto (India) Limited. It upholds a compliant status. Employing 1,197 professional, Its leadership includes Sharda Rohit Gupta (Whole-Time Director), Devesh Chandrakant Shah (Director), Kolappan Esaki Muthu (Whole-Time Director). Past directors included Girish Arjan Tekchandani, Gaurav Katyal, Sathia Jeeva Krishnan Chidambara. It holds no open charges and ₹11.58 Cr settled loans. Its latest AGM occurred on 02 September 2025, with the balance sheet filed on 31 March 2025. It is based at Bayer House, Central Avenue, Hiranandani Estate, Thane (West), Thane, Maharashtra, 400607.
U24110MH1996PTC096340
096340
16 January 1996
₹350.00 Cr
₹346.11 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Bayer Science And Innovation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharda Rohit Gupta | Whole-Time Director | 06 Nov 2023 | Current |
| Devesh Chandrakant Shah | Director | 06 Nov 2023 | Current |
| Kolappan Esaki Muthu | Whole-Time Director | 01 Sep 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 16 Oct 2008 | Past |
| Pramod Abcsdd | Director | 04 Feb 2022 | Past |
| Pramod Abcsdd | Additional Director | 16 Oct 2008 | Past |
| Pramod Abcsdd | Whole-Time Director | 08 Jun 2009 | Past |
| Pramod Abcsdd | Whole-Time Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 06 Nov 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bayer Science And Innovation Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.5% increase. The company also saw a substantial fall in profitability, with a 40.8% decrease in profit. The company's net worth moved up by a moderate rise of 8.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Bayer Science And Innovation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹115,750,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Apr 2001 | Canara Bank | ₹5.00 M | Satisfied |
| 04 Sep 2000 | Canara Bank | ₹6.00 M | Satisfied |
| 29 Sep 1997 | Canara Bank | ₹6.90 Cr | Satisfied |
| 20 Dec 1996 | Canara Bank | ₹5.00 M | Satisfied |
| 24 Jan 1996 | Canara Bank | ₹3.25 M | Satisfied |
Explore comprehensive loan charge details -
Bayer Science And Innovation has a workforce of 1197 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bayer Science And Innovation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bayer Science And Innovation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bayer Science And Innovation Private Limited last Annual general meeting of members was held on 02 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Bayer Science And Innovation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
The activity Sharda Rohit Gupta was appointed as a Whole-time director was appointed as a Whole-time director on 06 Nov 2023 & has been associated with this company since 2 years 1 month . was completed.
Progress on Devesh Chandrakant Shah was appointed as a Director was appointed as a Director on 06 Nov 2023 & has been associated with this company since 2 years 1 month . was documented.
The activity Kolappan Esaki Muthu was appointed as a Whole-time director was appointed as a Whole-time director on 01 Sep 2022 & has been associated with this company since 3 years 3 months . was completed.
A charge registered on 23 Apr 2001 via Charge ID 90165416 with Canara Bank was fully satisfied on 19 Dec 2019. was recorded as a recent event.
Biocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalmology product for neovascular and age-related macular degeneration, in Canada by July 1, 2025..
Sun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights to Sun Pharma to distribute Finerenone under the brand name Lyvelsa. Sun Pharma CEO emphasizes commitment to providing innovative medicines to Indian patients. .
Bayer raised the objection against Natcos brand launched under the name Regonat alleging infringement of its patent rights..
The CIN of Bayer Science And Innovation Private Limited is U24110MH1996PTC096340.
Bayer Science And Innovation Private Limited is headquartered at Bayer House, Central Avenue, Hiranandani Estate, Thane (West), Thane, Maharashtra, 400607.
Bayer Science And Innovation Private Limited was incorporated on 16 January 1996.
The current directors of Bayer Science And Innovation Private Limited are
The primary industry of Bayer Science And Innovation Private Limited is Agriculture, Forestry, Fishing.
Bayer Science And Innovation Private Limited is unlisted.
The authorized capital of Bayer Science And Innovation Private Limited is ₹350.00 Cr, and the paid-up capital is ₹346.11 Cr.
The compliance status of Bayer Science And Innovation Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX